Clinical trial
Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic…
NCT00048750 · Astellas Pharma Inc, Industry · Terminated
Key facts
| NCT number | NCT00048750 |
|---|---|
| Title | Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU |
| Official title | A Phase 3, Randomized,Double-Blind, Comparative Study of Micafungin (FK463) Versus Placebo as Preemptive Prophylactic Antifungal Therapy in Patients in the Intensive Care Unit |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Invasive Fungal Infections |
| Intervention type | Drug |
| Interventions | Micafungin, Placebo |
| Enrollment | 104 |
| Start date | Jan 1, 2003 |
| Primary completion | Jun 1, 2003 |
| Completion | Jun 1, 2003 |
| First posted | Nov 8, 2002 |
| Last update posted | Mar 27, 2012 |
| Countries | Canada, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: